Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0013950 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Ange-Marie D Kpetigo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France. Hauptthemen laut MEDLINE: Ebola Vaccines, Antibodies, Viral, Hemorrhagic Fever, Ebola, Ebolavirus. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NCI NIH HHS, NIH HHS, U.S. National Institutes of Health.
Abstract (Originalsprache)
Background Emerging evidence suggests that the time in the day of vaccination may influence post-vaccination immunogenicity. The main objective of this study was to assess the association between the time of vaccination and the anti-EBOV GP 1,2 IgG antibody response at 12 mo following vaccination against Ebola virus disease (EVD). Methodology/Principal Findings This study utilized data from a randomized, double-blind, placebo-controlled international phase 2b clinical trial (PREVAC) evaluating the immunogenicity of three vaccination strategies against Ebola virus disease (rVSVΔG-ZEBOV-GP one and two doses, and Ad26.ZEBOV/MVA-BN-Filo) in 1,859 healthy Western Africans. In the overall population, we measured a statistically significant association between the time of day of first vaccination and anti-Ebola virus immunoglobulin G levels at 12 mo ( p = 0.02). The magnitude of this association was small, participants vaccinated at 1600 h were estimated to have 1–7% lower antibody levels at 12 mo compared to those vaccinated at 1000 h. Conclusions/Significance An effect of the time of first vaccination on the antibody responses was found but remains modest and unlikely to impact the EVD vaccine effectiveness. Clinical Trials Registration ClinicalTrials.gov registration: NCT02876328 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.
- Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médicine, Créteil, France.
- Inserm, Paris, France.
- Centre National de Formation et de Recherche en Santé Rurale (CNFRSR) de Mafèrinyah, Ministère de la Santé et de l'Hygiène Publique, Mafèrinyah, Guinea.
- University Clinical Research Center (UCRC), University of Sciences, Technique and Technology of Bamako (USTTB), Bamako, Mali.
- Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
ORCID-Profile: Edouard Lhomme
Förderung
- NCI NIH HHS
- NIH HHS
- U.S. National Institutes of Health
- INSERM
- London School of Hygiene and Tropical Medicine
- EDCTP2
- Innovative Medicines Initiative
- National Cancer Institute
Zitieren
APA
Kpetigo, A. D., Alexandre, M., Camara, A., Beavogui, A., Doumbia, S., Kieh, M., Leigh, B., Sow, S., Wittkop, L., Soutthiphong, A. A., Berry, I. M., Fleck, S., Akoo, P., Hamze, B., Watson-Jones, D., Kuhn, J. H., Greenwood, B., Richert, L., Yazdanpanah, Y., …, & Lhomme, E. (2026). Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013950
Vancouver
Kpetigo AD, Alexandre M, Camara A, Beavogui A, Doumbia S, Kieh M, et al. Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0013950
BibTeX
@article{Kpetigo2026,
author = {Kpetigo, Ange-Marie D and Alexandre, Marie and Camara, Aboubacar and Beavogui, Abdoul and Doumbia, Seydou and Kieh, Mark and Leigh, Bailah and Sow, Samba and Wittkop, Linda and Soutthiphong, Anne-Aygline and Berry, Irina Maljkovic and Fleck, Suzanne and Akoo, Pauline and Hamze, Benjamin and Watson-Jones, Deborah and Kuhn, Jens H and Greenwood, Brian and Richert, Laura and Yazdanpanah, Yazdan and Lévy, Yves and Thiébaut, Rodolphe and Prague, Mélanie and PREVAC Study Team, PREVAC Study Team and Lhomme, Edouard},
title = {Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0013950}
}
EUVIMED